Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Abbott Laboratories    ABT

ABBOTT LABORATORIES (ABT)
Mes dernières consult.
Most popular
Report
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 201420152016201720182019
Sales20 24720 40520 85327 18030 15231 935
EBITDA3 8654 8504 9756 9757 8398 551
Operating profit (EBIT)2 8723 9794 1725 8206 5847 159
Pre-Tax Profit (EBT)------
Net income2 2844 4231 4002 1532 7762 980
P/E ratio30,215,440,948,135,730,7
EPS ( $ )1,492,920,941,171,581,84
Dividend per Share ( $ )0,900,981,041,071,111,18
Yield2,00%2,18%2,71%1,90%1,97%2,10%
Reference price ( $ )45.0244.9138.4156.3256.3256.32
Announcement Date01/29/2015
12:45pm
01/28/2016
12:31pm
01/25/2017
12:45pm
---
Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 201420152016201720182019
Debt3 7822 8763 23120 40317 82814 603
Finance------
Operating income (EBITDA)3 8654 8504 9756 9757 8398 551
Leverage
(Debt/EBITDA)
0,98x0,59x0,65x2,93x2,27x1,71x
Capital Expenditure1 0771 1101 1211 1381 3051 329
Book Value Per Share (BVPS)14,3 $14,4 $13,9 $16,8 $17,5 $18,7 $
Cash Flow per Share2,41 $1,97 $2,16 $2,45 $3,66 $4,20 $
Announcement Date01/29/2015
12:45pm
01/28/2016
12:31pm
01/25/2017
12:45pm
---
Balance Sheet Analysis
Assessed data source :
© 2017 Thomson Reuters
Financial Ratios

Size 2017e 2018e
Capitalization 97 853 M$ -
Entreprise Value (EV) 118 256 M$ 115 681 M$
Valuation 2017e 2018e
P/E ratio (Price / EPS) 48,1x 35,7x
Capitalization / Revenue 3,60x 3,25x
EV / Revenue 4,35x 3,84x
EV / EBITDA 17,0x 14,8x
Yield (DPS / Price) 1,90% 1,97%
Price to book (Price / BVPS) 3,35x 3,21x
Profitability 2017e 2018e
Operating Margin (EBIT / Sales) 21,4% 21,8%
operating Leverage (Delta EBIT / Delta Sales) 1,30x 1,20x
Net Margin (Net Profit / Revenue) 7,92% 9,21%
ROA (Net Profit / Asset) 6,55% 7,40%
ROE (Net Profit / Equities) 17,0% 18,0%
Rate of Dividend 91,4% 70,3%
Balance Sheet Analysis 2017e 2018e
CAPEX / CA   4,19% 4,33%
Cash Flow / Sales 15,6% 21,1%
Capital Intensity (Assets / Sales) 1,21x 1,24x
Financial Leverage (Net Debt / EBITDA) 2,93x 2,27x
EPS & Dividend